| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |